Phathom Pharmaceuticals to Share VOQUEZNA Data at ACG 2024 Annual Meeting
Phathom Pharmaceuticals to Share VOQUEZNA Data at ACG 2024 Annual Meeting Description: FLORHAM PARK, N.J., Oct. 27, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the company will present data from multiple investigational studies for its first-in-class…